发明名称 |
Compounds, compositions and methods |
摘要 |
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure. |
申请公布号 |
US9150564(B2) |
申请公布日期 |
2015.10.06 |
申请号 |
US201414489705 |
申请日期 |
2014.09.18 |
申请人 |
CYTOKINETICS, INC. |
发明人 |
Morgan Bradley Paul;Muci Alex;Lu Pu-Ping;Kraynack Erica Anne;Tochimoto Todd;Morgans, Jr. David J. |
分类号 |
A61K31/54;A61K31/535;A61K31/44;A61K31/445;A61K31/497;C07D417/12;C07D401/12;C07D213/75;C07D211/56;C07D239/42;C07D261/14;C07D263/48;C07D271/113;C07D295/26;C07D401/10;C07D417/10;C07D487/04;C07D491/04;C07D513/04;C07D417/00 |
主分类号 |
A61K31/54 |
代理机构 |
Marshall Gerstein & Borun LLP |
代理人 |
Marshall Gerstein & Borun LLP |
主权项 |
1. A method of increasing cardiac contractility of cardiac tissue without changing the calcium transient comprising contacting the cardiac tissue with methyl-4-(2-fluoro-3-(6-methylpyridin-3-yl)benzyl)piperazine-1-carboxylate having the structure:or a pharmaceutically acceptable salt thereof. |
地址 |
South San Francisco CA US |